Skip to main content
. 2006 Mar 21;94(7):1066–1070. doi: 10.1038/sj.bjc.6603037

Figure 3.

Figure 3

(A) Survival of patients as a function of the detection of autoantibodies to endostatin. Kaplan–Meier analysis showed that patients with detectable endostatin autoantibodies had significantly longer overall survival (P=0.03). (B) Survival of patients as a function of serum endostatin levels. Kaplan–Meier analysis showed that patients with lower serum endostatin levels had significantly longer overall survival (P=0.007).